{
  "id": 16548059,
  "title": "Medical products regulator 'aims to boost innovation'",
  "url": "https://urgent.news/2026/10/26/medical-products-regulator-aims-to-boost-innovation-16548059",
  "topic": "world",
  "section": "World",
  "published": "2026-10-26T01:21:42.000Z",
  "source": {
    "name": "RTHK News",
    "slug": "rthk-news",
    "url": "https://news.rthk.hk/rthk/en/component/k2/1875318-20261026.htm"
  },
  "original_language": "en",
  "account": "A new regulatory body for medical products in Hong Kong is set to be established by the end of the year, according to its controller Li Zili. The Hong Kong Centre for Medical Products Regulation aims to bolster international trust, serve patients worldwide, and promote medical innovation, stated Li during an interview with reporters. The center's mission is to safeguard public health while encouraging the advancement of medical technology.\n\nLi emphasized the importance of building a regulatory authority with robust capabilities that are recognized globally. He explained that the center's \"primary evaluation\" process, which will be implemented in the future, should complement existing frameworks and strengthen the center's trustworthiness within the international community through a scientific and transparent regulatory system. Li added that the center will not only act as a bridge connecting the mainland and the world but also foster medical reforms and innovations.\n\nDirector of Health Ronald Lam confirmed that Li possesses practical experience in regulatory affairs and public health, and is well-versed in international medical product policies. Lam expressed confidence in Li's ability to reform the system, citing his experience and leadership skills.",
  "summary": "A new regulatory authority for medical products in Hong Kong aims to gain international trust and serve patients around the world, according to its controller Li Zili. The Hong Kong Centre for Medical Products Regulation, which will be established in the SAR by the end of the year, is expected to promote the “primary evaluation” of drugs and medical devices to speed up their clinical application.…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}